Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
24 avr. 2024 17h25 HE
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases
24 avr. 2024 07h00 HE
|
Biolojic Design
Nektar Therapeutics Has Exercised Its License Option to Develop Biolojic Design's AI-Designed Antibody Targeting TNFR2 in Immunology
Biologics Market Size Expected to Reach USD 845.78 Billion by 2033
12 mars 2024 11h20 HE
|
Precedence Research
Ottawa, March 12, 2024 (GLOBE NEWSWIRE) -- The global biologics market size was valued at USD 419.07 billion in 2023 and is projected to surpass around USD 698.17 billion by 2031, a study published...
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
06 mars 2024 23h58 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing...
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
06 mars 2024 16h32 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it...
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
06 mars 2024 16h31 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Biologics Contract Development & Manufacturing Organization Market revenue to hit USD 39 Billion by 2036, says Research Nester
08 févr. 2024 05h30 HE
|
Research Nester
New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics contract development & manufacturing organization (CDMO) market size is projected to grow at a CAGR of over ~12% from 2024 to...
Prefilled Syringes Market Size to Surpass USD 72.9 Billion by 2033 Owing to the Increasing Prevalence of Chronic Diseases
22 janv. 2024 13h30 HE
|
Market.Us
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Prefilled Syringes Market size is forecasted to exceed US$ 72.9 Billion by 2033, with a promising CAGR of 12.3% from...
Biologics Market Size Estimated to Reach USD 620.31 Billion by 2032
08 janv. 2024 11h15 HE
|
Precedence Research
Ottawa, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics market size accounted for USD 387.73 billion in 2024, grew to USD 409.84 billion in 2025 and the industry is expanding at a CAGR of 6%...
Biologics Market Growth CAGR 6.9% During 2023-2032 | Xcellent Insights
03 janv. 2024 03h00 HE
|
XCELLENT INSIGHTS LLP
Pune, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global biologics market is expected to register a rapid revenue CAGR of 6.9% during the forecast period. This growth can be attributed to factors such...